Gjensidige Forsikring ASA (GJF)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 270.40 |
|---|---|
| 52-week range | 241.40 – 303.00 |
| Return, 1 month / 3 months | −0.1% / −4.0% |
| Return, 1 year / 3 years | +2.1% / +90.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 60 |
| Volatility (1 year) | 19.5% |
| Worst drawdown (1 year) | -15.4% |
| Average daily value traded | 74.68M NOK |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gjensidige Forsikring is an insurance company based in Norway. It provides property and casualty insurance to private households and to businesses, covering areas such as homes, vehicles and commercial risks. The company also offers pension and savings products to its customers. Its main market is Norway, and it serves both individual policyholders and corporate clients through its insurance operations.
On this site Gjensidige Forsikring ASA appears as a stock on the Oslo Stock Exchange (Norway), code GJF, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gjensidige Forsikring ASA (GJF) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 270.40 on 22 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 55 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.1% and over the last three months it fell 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.6% | ||
| From 52-week high | -10.5% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.0% | ||
| 6-month return | 2.7% | ||
| 12-month return, skipping the last month | 2.3% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.4% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 74.68M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +4.2% |
|---|---|
| 1 month | −0.1% |
| 3 months | −4.0% |
| 6 months | +2.7% |
| 1 year | +2.1% |
| 3 years | +90.6% |
| 5 years | +65.5% |
Signals
| 50-day / 200-day average | 270.45 / 263.54 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | NOK 14.5000 |
| 21 Mar 2025 | NOK 10.0000 |
| 21 Mar 2024 | NOK 8.7500 |
| 24 Mar 2023 | NOK 8.2500 |
| 25 Mar 2022 | NOK 7.7000 |
| 8 Nov 2021 | NOK 4.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.